Kenneth Blum

1.8k total citations
16 papers, 1.3k citations indexed

About

Kenneth Blum is a scholar working on Cellular and Molecular Neuroscience, Molecular Biology and Pharmacology. According to data from OpenAlex, Kenneth Blum has authored 16 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Cellular and Molecular Neuroscience, 6 papers in Molecular Biology and 4 papers in Pharmacology. Recurrent topics in Kenneth Blum's work include Neurotransmitter Receptor Influence on Behavior (12 papers), Receptor Mechanisms and Signaling (6 papers) and Pharmacology and Obesity Treatment (3 papers). Kenneth Blum is often cited by papers focused on Neurotransmitter Receptor Influence on Behavior (12 papers), Receptor Mechanisms and Signaling (6 papers) and Pharmacology and Obesity Treatment (3 papers). Kenneth Blum collaborates with scholars based in United States, Taiwan and Spain. Kenneth Blum's co-authors include Eric R. Braverman, Peter J. Sheridan, Robert C. Wood, John G. Cull, David E. Comings, Ernest P. Noble, Thomas J.H. Chen, George R. Uhl, Stevens S. Smith and Robert J. Fitch and has published in prestigious journals such as SHILAP Revista de lepidopterología, Trends in Neurosciences and Cellular and Molecular Life Sciences.

In The Last Decade

Kenneth Blum

15 papers receiving 1.3k citations

Peers

Countries citing papers authored by Kenneth Blum

Since Specialization

Citations

This map shows the geographic impact of Kenneth Blum's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kenneth Blum with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kenneth Blum more than expected).

Fields of papers citing papers by Kenneth Blum

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kenneth Blum. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kenneth Blum. The network helps show where Kenneth Blum may publish in the future.

Co-authorship network of co-authors of Kenneth Blum

This figure shows the co-authorship network connecting the top 25 collaborators of Kenneth Blum. A scholar is included among the top collaborators of Kenneth Blum based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kenneth Blum. Kenneth Blum is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

16 of 16 papers shown

#	Work	Indexed citations
1	GWAS meta-meta-analysis and related analyses revealed a shared genetic background between ADHD and narcolepsy 2025 ·SHILAP Revista de lepidopterología ·Edward J. Modestino, (unknown), Kai‐Uwe Lewandrowski, Elizabeth J. Carey, (unknown), Panayotis K. Thanos, Albert Pinhasov, Abdalla Bowirrat, David Baron, (unknown), Igor Elman, Eliot L. Gardner, Brian Fuehrlein, (unknown), (unknown), (unknown), (unknown), Rajendra D. Badgaiyan, Kenneth Blum	0
2	NIDA-Drug Addiction Treatment Outcome Study (DATOS) Relapse as a Function of Spirituality/Religiosity 2015 ·PubMed ·Stephen J. Schoenthaler, Kenneth Blum, (unknown), John Giordano, Ben Thompson, Marlene Oscar‐Berman, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown)	35
3	Hypothesizing dopaminergic genetic antecedents in schizophrenia and substance seeking behavior 2014 ·Medical Hypotheses ·Kenneth Blum, Marlene Oscar‐Berman, (unknown), (unknown), (unknown)	11
4	Neurogenetics of Dopaminergic Receptor Supersensitivity in Activation of Brain Reward Circuitry and Relapse: Proposing “Deprivation-Amplification Relapse Therapy” (DART) 2009 ·Postgraduate Medicine ·Kenneth Blum, Thomas J.H. Chen, Bernard W. Downs, Abdalla Bowirrat, Roger L. Waite, Eric R. Braverman, Margaret Madigan, Marlene Oscar‐Berman, Nicholas A. DiNubile, Eric Stice, John Giordano, Siobhan Morse, Mark S. Gold	61
5	Attention-deficit-hyperactivity disorder and reward deficiency syndrome 2008 ·Neuropsychiatric Disease and Treatment ·(unknown), Kenneth Blum, Thomas J.H. Chen, Eric R. Braverman, (unknown), (unknown), Vanessa Arcuri, (unknown), Tomás Palomo, (unknown)	176
6	Manipulation of catechol-O-methyl-transferase (COMT) activity to influence the attenuation of substance seeking behavior, a subtype of Reward Deficiency Syndrome (RDS), is dependent upon gene polymorphisms: A hypothesis 2007 ·Medical Hypotheses ·Kenneth Blum, Thomas J.H. Chen, (unknown), Roger L. Waite, Bernard W. Downs, Seth H. Blum, (unknown), Vanessa Arcuri, Eric R. Braverman, Tomás Palomo	42
7	Synaptamine (SG8839),TM An Amino-Acid Enkephalinase Inhibition Nutraceutical Improves Recovery of Alcoholics, A Subtype of Reward Deficiency Syndrome (RDS) 2007 ·Trends in Applied Sciences Research ·Kenneth Blum, Thomas J.H. Chen, Bernard W. Downs, (unknown), Seth H. Blum, Manuel Martínez Pons, (unknown), Roger L. Waite, Vanessa Arcuri, (unknown), Eric R. Braverman	23
8	Are dopaminergic genes involved in a predisposition to pathological aggression? 2005 ·Medical Hypotheses ·Thomas J.H. Chen, Kenneth Blum, (unknown), (unknown), (unknown), Eric R. Braverman, John Schoolfield, Bernard W. Downs, David E. Comings	86
9	Increased prevalence of the Taq I A1allele of the dopamine receptor gene (DRD2) in obesity with comorbid substance use disorder: a preliminary report 1996 ·Pharmacogenetics ·Kenneth Blum, Eric R. Braverman, Robert C. Wood, James R. Gill, (unknown), Thomas J.H. Chen, (unknown), (unknown), Peter J. Sheridan, John G. Cull	117
10	The D₂ Dopamine Receptor Gene as a Determinant of Reward Deficiency Syndrome 1996 ·Journal of the Royal Society of Medicine ·Kenneth Blum, Peter J. Sheridan, Robert C. Wood, Eric R. Braverman, (unknown), John G. Cull, David E. Comings	345
11	Dopamine D2 receptor gene polymorphisms in Scandinavian chronic alcoholics: A reappraisal 1995 ·European Archives of Psychiatry and Clinical Neuroscience ·Kenneth Blum, Peter J. Sheridan, Robert G. Wood, Eric R. Braverman	3
12	Genetic predisposition in alcoholism: Association of the D2 dopamine receptor TaqI B1 RFLP with severe alcoholics 1993 ·Alcohol ·Kenneth Blum, Ernest P. Noble, Peter J. Sheridan, Anne Montgomery, T. Ritchíe, Tulin Ozkaragoz, Robert J. Fitch, Robert G. Wood, (unknown), (unknown)	101
13	Substance abuse vulnerability and D2 receptor genes 1993 ·Trends in Neurosciences ·George R. Uhl, Kenneth Blum, Ernest P. Noble, Stevens S. Smith	107
14	Allelic association of the D2 dopamine receptor gene with cocaine dependence 1993 ·Drug and Alcohol Dependence ·Ernest P. Noble, Kenneth Blum, M. Elena Khalsa, Terry Ritchie, Anne Montgomery, Robert C. Wood, Robert J. Fitch, Tulin Ozkaragoz, Peter J. Sheridan, M. Douglas Anglin, Alfonso Paredes, Lucy J. Treiman, Robert S. Sparkes	209
15	Introduction 1989 ·Cellular and Molecular Life Sciences ·Kenneth Blum	1
16	The effect of dopamine and other catecholamines on neuromuscular transmission. 1969 ·PubMed ·Kenneth Blum	12

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact